在病态肥胖的非吸烟者中进行支气管扩展剂可逆性测试:流动/沙米特醇疗效与沙布塔摩尔支气管扩展剂相比
Mona Ibrahim Ahmed1, Randa Ibrahim Ahmed1, Hasnaa Osama2
1Department of chest Ds & TB, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
BMC pulmonary medicine
|October 9, 2023
概括
西/沙米特醇组合显示出比单独的沙布塔摩尔更大的呼吸道可逆性,特别是在肥胖个体中. 这表明它有可能使用可逆性测试来诊断肥胖患者的呼吸道阻塞.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床试验 临床试验
背景情况:
- 呼吸道可逆性测试对于诊断阻塞性肺部疾病至关重要.
- 传统的测试可能无法完全捕捉气道不可逆性,特别是在特定人群中.
- 肥胖与改变的呼吸机制和潜在的气道变化有关.
研究的目的:
- 为了评估使用沙布他摩尔与流他/沙米特罗尔组合的支气管扩张可逆性测试的疗效.
- 评估这些治疗对非吸烟者呼吸道可逆性的影响,重点关注肥胖人口.
主要方法:
- 一项涉及415名不吸烟者的研究,根据体重指数 (BMI) 分类:正常,超重和肥胖.
- 螺旋计测量在服用沙布塔摩尔或流沙/沙米特罗尔之前和之后进行.
- 统计分析比较了治疗组和BMI类别之间的螺旋计结果.
主要成果:
- 肥胖的人群中,限制性肺模式的患病率很高 (23.4%).
- 与沙尔布塔摩尔相比,流动/沙尔米特醇组合显示出明显更大的支气管扩张效果.
- 肥胖个体在FEV1,FEV1%预测和FEV1/FVC比率与流动/沙米特醇 (p<0.05) 显著改善.
结论:
- 在评估呼吸道可逆性方面,流动/沙米特醇组合比沙布塔摩尔更有效.
- 这种组合疗法是评估气道阻塞的潜在工具,特别是在肥胖人口中.
- 进一步的研究可能会验证其在临床诊断中用于肥胖的呼吸道限制.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
278
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
278
01:26COPD: Management Using Bronchodilators and Corticosteroids
218
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
218
01:23Inhaled Medications
292
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
292
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
462
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
462
01:20Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421